United States· US:58264-0326_2b50da62-0299-1c5f-e063-6394a90ade94
A-34
A medicinal product containing saccharomyces cerevisiae, registered in United States by DNA Labs, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SACCHAROMYCES CEREVISIAE
- Manufacturer
- DNA Labs, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1158264-0326-1
- ndc11582640326129.57 mL in 1 BOTTLE, GLASS (58264-0326-1)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Saccharomyces cerevisiae in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainULTRA LEVURA 50 MG CAPSULAS DURASBiocodex
- BelgiumAntediar 125 mgWill Pharma
- CzechiaENTEROLBIOCODEX, Gentilly
- GermanyBoulardii Pz Entsprechend Mindestens 10^10 Lebensfähige Zellen/G, LyophilisiertPharma Zentrale Gmbh
- FinlandPrecosa2care4 ApS
- United KingdomBiome Balance For those on Antibiotics 300mg capsulesLamberts Healthcare Ltd
- NorwayCodex 5 miliardiBiocodex
- PolandEnterolBIOCODEX
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Yomogi
- Belgium · Sacchiflora
- Cyprus · Bioflor
- Germany · Boulardii Pz Entsprechend Mindestens 10^10 Lebensfähige Zellen/G, Lyophilisiert, Ceritract
- Italy · Codex, Preparazione H
- Portugal · Prolif
- Sweden · Precosa
- Slovakia · Yomogi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8fe8d021-2e0b-4c11-b14c-eebb2cbe86db GET /v1/drugs/8fe8d021-2e0b-4c11-b14c-eebb2cbe86db?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBLINGUAL",
"source": "ndc",
"strength": "30",
"substance": "SACCHAROMYCES CEREVISIAE",
"productndc": "58264-0326",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "[hp_X]/mL",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about saccharomyces cerevisiae.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.